Rubraquercus, Cash for ongoing operations is al
Post# of 148166
(Total Views: 586)
Posted On: 10/22/2020 11:26:47 PM
Re: Rubraquercus #62825
Rubraquercus,
Cash for ongoing operations is always a concern when there are no sales. Cytodyn needs to be prudent in their use of money, but they are in a much better place now than they were years past.
I don't know all the history but SAF, Omandarin, CDIddy, Shelly, Ohm, TechG and others (I don't know all the super longs off hand) can certainly articulate the painful dilution when SP was well under $1.
I have not kept track of the supplies, but last I read here there are 300K vials on hand and 800K that are produced, just need to be filled. That is substantially more than Regeneron has available for their anti-viral mAb.
I am cautiously optimistic that EU, UK or Philippines will come through. The death rate, while diminishing remains significant.
US 1,100 a day now. I have to kept track with the rest of the world other than knowing that case are increasing. I assume that someone will realize that remdesivir is an insufficient solution and that leronlimab is the real do.
Cash for ongoing operations is always a concern when there are no sales. Cytodyn needs to be prudent in their use of money, but they are in a much better place now than they were years past.
I don't know all the history but SAF, Omandarin, CDIddy, Shelly, Ohm, TechG and others (I don't know all the super longs off hand) can certainly articulate the painful dilution when SP was well under $1.
I have not kept track of the supplies, but last I read here there are 300K vials on hand and 800K that are produced, just need to be filled. That is substantially more than Regeneron has available for their anti-viral mAb.
I am cautiously optimistic that EU, UK or Philippines will come through. The death rate, while diminishing remains significant.
US 1,100 a day now. I have to kept track with the rest of the world other than knowing that case are increasing. I assume that someone will realize that remdesivir is an insufficient solution and that leronlimab is the real do.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼